Lionel Apetoh

20PUBLICATIONS
57CO-AUTHORS
Molecular targetsMedical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 19, 2026
Single-cell multiomics reveals exosome-mediated reprogramming and clonotypic remodeling of T cells in triple-negative breast cancer.

|Jan 16, 2026
Stearoyl-CoA desaturase-1 controls the differentiation and antitumoral function of Th9 lymphocytes.

Emma Groetz, Sabrina Perrey, Alvaro Baeza Garcia

|Apr 28, 2025
Go to the scene: TH9 cells superior migration ability to the lungs explains their exceptional anticancer efficacy.

Jiazhi Xu, Lionel Apetoh

|Apr 08, 2025
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs.

Théo Accogli, Christophe Hibos, Lylou Milian

|Jun 21, 2023
B-cell-specific checkpoint molecules that regulate anti-tumour immunity.

Lloyd Bod, Yoon-Chul Kye, Jingwen Shi

|May 16, 2023
The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy.

Daria Vinokurova, Lionel Apetoh

Pageof 4

Frequent Collaborators

4 joint publications

François Ghiringhelli

3 joint publications

Romain Boidot

3 joint publications

Christophe Hibos

3 joint publications

Frédérique Végran